About Us

Our experienced team of researchers and clinical advisors collaborate to improve IOM technology and the quality of life for patients.

Company History

For over 30 years, CEO and founder Jeffrey Owen, Ph.D., has led much scientific, clinical, and technological development in Intraoperative Monitoring (IOM), and started and led IOM programs at multiple universities, as well as one of the US’s largest private providers, serving over 600 hospitals at its peak.

Despite the progress, Dr. Owen and his collaborators observed that most patients still couldn’t access IOM and that many more high-risk surgeries could also benefit from IOM. In 2019, he started NeuroVascular Research & Design with the goal of developing an automated IOM platform to bring reliable, accurate, and affordable monitoring to preserve the quality of life for all patients.

Meet Our Team

CEO Jeffrey Owen is joined by COO Nicholas Chung and CMO John Farhner in developing their reliable, automated IOM technology.
Jeffrey Owen, Ph.D.
Founder, Chief Executive Officer (CEO)

Jeffrey Owen received his Ph.D. in Neuroscience from The University of Arizona, emphasizing auditory neurophysiology. Following graduation, Dr. Owen took a position as an Assistant Professor in the Department of Neurology at The University of Kansas Medical Center (KUMC). At KUMC, Dr. Owen ran the evoked potential laboratory and developed the intra-operative monitoring (IOM) program for Neurosurgery and Orthopedic Surgery.

Nicholas Chung
Co-founder, Chief Operating Officer (COO)

Nicholas Chung is an experienced business, software, software/product development, and entrepreneurship leader. Most recently, he was a Lead Director of Custom Solutions at The Trade Desk, where he led a professional services practice and established the European practice and team during a period of hyper-growth. He has degrees from Brown and Columbia universities.

Our Clinical Advisors

Paul D. Sponseller, M.D.

Paul D. Sponseller, M.D. obtained his undergraduate and medical degrees from the University of Michigan. He completed his Orthopaedic residency at the University of Wisconsin and a Pediatric Orthopaedics fellowship at Boston Children’s Hospital/Harvard Medical School, finishing in 1986. In 2004, he earned an MBA at Johns Hopkins University.

Arthur L. “Bud” Burnett II, MD, MBA, FACS
Dr. Burnett is the Patrick C. Walsh Distinguished Professor of Urology and Professor, Oncology Center at the Johns Hopkins University School of Medicine. He is an accomplished urologic surgeon and scientist, recognized for diverse leadership and service roles in urologic healthcare across research, education, clinical practice, and advocacy missions.
Amit Jain, MD, MBA
Chief Medical Officer

Amit Jain, MD, MBA, is a leader and innovator in spine surgery. He is an Associate Professor of Orthopaedic Surgery and Neurosurgery and is the Chief of Minimally Invasive Spine Surgery at Johns Hopkins. Dr. Jain received his B.S. in Bioengineering with High Honors at UC Berkeley. After attending Hopkins for medical school, he received the prestigious Paul and Daisy Soros Fellowship.